Ceftaroline fosamil
- Generic Name
- Ceftaroline fosamil
- Brand Names
- Teflaro, Zinforo
- Drug Type
- Small Molecule
- Chemical Formula
- C22H21N8O8PS4
- CAS Number
- 229016-73-3
- Unique Ingredient Identifier
- 7P6FQA5D21
- Background
Ceftaroline fosamil is a cephalosporin antibacterial indicated for the treatment of the following infections caused by designated susceptible bacteria:
Acute bacterial skin and skin structure infections.
Community-acquired bacterial pneumonia.
- Indication
Ceftaroline fosamil is indicated for the treatment of patients with the following infections caused by susceptible isolates of the designated microorganisms.
- Associated Conditions
- Acute Bacterial Skin and Skin Structure Infection (ABSSSI), Community-Acquired Bacterial Pneumonia (CABP)
- Associated Therapies
- -
Comparative Study of Ceftaroline vs. Vancomycin Plus Aztreonam in Adult Subjects With Complicated Skin Infections
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2007-01-18
- Last Posted Date
- 2017-03-14
- Lead Sponsor
- Forest Laboratories
- Target Recruit Count
- 680
- Registration Number
- NCT00423657
- Locations
- 🇬🇧
Investigational Site, London, United Kingdom
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath